Portfolio
Quantum Technology Partners invests in early stage technology and
life sciences companies.
 Anterios, Inc., headquartered
in New York, NY is
a privately held clinical stage biopharmaceutical company that is
developing next-generation botulinum-based prescription products for
medical dermatology and aesthetic medicine. Anterios has developed the
proprietary NDSTM platform technology that enables local, targeted delivery
of botulinum toxin and other macromolecules across the skin without needles
or other invasive treatments that can be destructive to the skin.
Co-investors include Ascent Biomedical Ventures and Scientific Health
Development, Ltd.
 BiPar Sciences, Inc., headquartered
in South San Francisco, CA, was acquired by Sanofi.
(NYSE:SNY). BiPar was in the development
and commercialization of novel therapies to treat cancers for which current
therapies are inadequate and/or are commonly associated with debilitating
side effects. The Company's initial focus is the
development and commercialization of three pre clinical, small
molecule drug candidates for the treatment of breast and ovarian cancers.
Co-investors include Domain Associates, Vulcan Capital, Canaan Partners and
Asset Management Company.
 Corium International, Inc., (NASDAQ:
CORI) headquartered in Menlo Park, CA is engaged in the research,
development and manufacture of advanced transdermal drug delivery
technologies and products. Using its proprietary delivery technologies and
its development and manufacturing expertise, Corium has developed a number
of active and passive transdermal products with enhanced therapeutic or
safety profiles. Essex Woodlands was the lead co-investor.
 PeriNess Ltd., located in
Ramat Gan, Israel is a biopharmaceutical company
that is committed to, and engaged in the development of a new drug for
enhancement of male fertility. The company has discovered a
unique enzyme that can significantly enhance the fertility of
sub-fertile males, based on technology that was developed by Professor
Benjamin Bartoov from the Faculty of Life Sciences at Bar-Ilan University.
 Ploom, Inc., based in San Francisco, is
leading the reinvention of the smoking experience with its premium loose
leaf and pod-system vaporizers. Ploom creates superior, beautiful and
technologically advanced products that redefine the future of the tobacco
industry. Co-investors include Japan Tobacco International and Tao
Capital.
 S.E.A.Medical
Systems, Inc. is a private health-tech company that pioneers smart
solutions for the safe manufacture, preparation, delivery, and disposal of
intravenous and other liquid medications. The Company is developing medical
devices to catch life-threatening IV drug errors before they harm patients.
 SPI Lasers Plc (formerly
Southampton Photonics), based in Southampton, U.K. was acquired by TRUMPF
GmbH + Co. SPI is a leader in high
power fiber lasers in the industrial, aerospace, analytical, sensing and
communications markets. Co-investors include Advent Venture Partners,
Amadeus Capital Partners, InterWest Partners and Sevin Rosen.
 Vaxart, Inc.,
located in San Francisco, California, is a biotechnology company developing
oral vaccinations against infectious diseases. Vaxart's
proprietary technology permits rapid, low cost, high volume production of
orally delivered vaccines for a wide range of infectious agents. Quantum
co-led the Series A financing with Life Science Angels. Bay Partners also
participated in the financing.
|
